Biomedical applications of NIR-II organic small molecule fluorescent probes in different organs
Lizhen Xu,Qian Zhang,Xin Wang,Weiying Lin
DOI: https://doi.org/10.1016/j.ccr.2024.216122
IF: 24.833
2024-01-01
Coordination Chemistry Reviews
Abstract:The optimal functioning of body organs is fundamental to maintaining physiological processes and bodily health. However, a myriad of factors, including inherent and environmental variables, potentially contribute to the development of severely organ dysfunction and pathologies, manifesting in conditions such as stroke, epilepsy, hepatocellular carcinoma, renal injury, myocardial infarction, pneumonia, colorectal cancer, and thrombosis. These diseases severely compromise organ function, sometimes rendering organ non-functional. The ability to non-invasively and continuously monitor organ function during disease progression and treatment is of paramount importance in the context of pathophysiological research and therapeutic assessment. In recent years, the fluorescence probes for in vivo imaging have led to its emergence as a promising technology to meet the stringent requirements of real-time monitoring, without impinging upon normal physiological processes. Furthermore, fluorescent probes have demonstrated a considerable potential in the biomedical field due to their advantages such as rapid response time, high sensitivity, high selectivity, non-invasive imaging capabilities, and ability for real-time high-resolution spatiotemporal imaging. Typically, fluorescent probes are categorized into three distinct groups according to the wavelength of emission: visible fluorescent probes, Near-infrared (NIR-I)-region (700–900 nm) fluorescent probes, and Near-infrared (NIR-II) region (1000–1700 nm) fluorescent probes. Compared to the NIR-I fluorescence imaging (NIR-I FLI) -window, the NIR-II FL imaging (NIR-II FLI) window exhibits lower light scattering and reduced auto-fluorescence from organs, thereby enabling enhanced tissue penetration and a significantly expanded bio-imaging applications. This advancement promises to provide the clinical arsenal with an expanded array of potential diagnostic and therapeutic tools for early disease management. In the recent years, many efforts have been devoted to fluorescent probes for in vivo FLI and related disease therapy, a comprehensive systematic review on the advancements of NIR-II organic fluorescent molecules for various diseased organs imaging is currently vacant. This deficiency may severely hinder the further application of NIR-II organic fluorescent probes for early disease diagnosis and therapy.Therefore, in this review, the classification of NIR-II organic fluorescent probes was based on their NIR-II FLI ability in different diseased organs (tumors, blood vessels, brain, lymph nodes, liver, lungs, kidneys, gastrointestinal tract, etc.), and a comprehensive overview of the biological applications of NIR-II organic fluorescent probes in the diagnosis and therapy of various diseases was provided. In addition, we also deeply discussed the limitations of NIR-II organic fluorescent probes and the potential of NIR-II organic fluorescent probes in the biomedical application and drug research.